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Summary Genome-mismatch scanning (GMS) is one such short-
cut linkage technique (Nelson et al. 1993; Nelson 1995).
Genome-mismatch scanning (GMS) is a new method of
DNA fragments from all regions of identity by descent
linkage analysis that rapidly isolates regions of identity
(IBD) between two related individuals are isolated on
between two genomes. DNA molecules from regions of
the basis of their ability to form extended mismatch-free
identity by descent from two relatives are isolated based
‘‘heterohybrids’’ (one strand from each individual). The
on their ability to form extended mismatch-free hetero-
DNA from one individual is methylated before hybrid
duplexes. We have applied this rapid technology to iden-
formation, and heterohybrids are isolated by use of a
tify the chromosomal region shared by two ﬁfth-degree
combination of methylation-dependent and sensitive re-
cousins with autosomal dominant iridogoniodysgenesis
striction endonucleases. Heterohybrid molecules con-
anomaly (IGDA), a rare ocular neurocristopathy. Mark-
taining mismatches are nicked by the Escherichia coli
ers on the short arm of human chromosome 6p were
MutHLS enzyme system and are eliminated. The resul-
recovered, consistent with the results of conventional
tant GMS-selected DNA can then be assayed in simple
linkage analysis conducted in parallel, indicating linkage
plus/minus tests to determine if conventional microsatel-
of IGDA to 6p25. Control markers tested on a second
lite markers have been retained. PCR-testable marker
human chromosome were not recovered. A GMS error
loci contained within the IBD regions of the two individ-
rate of Ç11% was observed, well within an acceptable
uals used for GMS will produce PCR products, whereas
range for a rapid, ﬁrst screening approach, especially
loci outside such IBD regions will not generate PCR
since GMS results would be conﬁrmed by family analysis
products.
with selected markers from the putative region of iden-
We have conducted both conventional linkage analy-
tity by descent. These results demonstrate not only the
sis and GMS tomap the location of iridogoniodysgenesis
value of this technique in the rapid mapping of human
anomaly (IGDA), a rare autosomal dominant ocular
genetic traits, but the ﬁrst application of GMS to a multi-
neurocristopathy. Linkage analysis with two kindreds
cellular organism.
with IGDA, the ﬁrst originating from the Maritime re-
gion of Canada and the second originating from south-
Introduction ern Wales, mapped IGDA to an 8.3-cM region of 6p25,
distal to D6S477. In parallel with these experiments,
The important ﬁrst step for all investigators using posi-
GMS was applied to two ﬁfth-degree cousins from one
tional cloning strategies to map human disease loci is to
IGDA family. Markers from 6p were recovered in the
ﬁnd genomic regions that are shared between affected
GMS-selected DNA pool, not only conﬁrming the link-
individuals. The recent availability of detailed human
age results but clearly demonstrating that GMS is a rapid
chromosome maps and highly informative marker loci
method of isolating regions of identity between two re-
have made relatively routine the conducting of ge-
lated humans sharing the same disease trait.
nomewide scans to map disease loci. However, since
such research often still involves tens of thousands of
Subjects, Material, and Methodsgenotypings, short-cut methods allowing one to rapidly
ﬁnd the locations of disease loci are still required.
Clinical Analysis
Individuals from a large family in which IGDA was
segregating (ﬁg. 1) were examined with standard slit-Received February 6, 1997; accepted for publication May 1, 1997.
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Figure 1 Pedigree of the family demonstrating autosomal dominant IGDA. Circles represent females, and squares represent males; affected
individuals are indicated by blackened symbols. A diagonal line through symbol indicates that the individual is deceased. Individuals VII:5 and
VII:7, two ﬁfth-degree cousins selected for GMS, are indicated by asterisks (*).
tails have been reported elsewhere (Pearce et al. 1983; FPERT will result in the production of homohybrids
(two strands of the same individual that have reannealedMears et al. 1996). Intraocular pressures were consid-
ered abnormal atú21 mm Hg. The study and collection and are thus either methylated or unmethylated on both
DNA strands) and hemimethylated heterohybrids. DNAof blood samples from all individuals included in this
report were approved by the Research Ethics Board of was double-digested with DpnI and MboI, to cleave and
eliminate the methylated and unmethylated homohy-the Faculty of Medicine of the University of Alberta.
brids, leaving the heterohybrids intact. Three E. coli
GMS methyl-directed mismatch-repair enzymes—MutL,
Individuals VII:5 and VII:7, two ﬁfth-degree female MutS, and MutH (MutH and MutL were obtained from
cousins from a large IGDA family (ﬁg. 1), were selected Amersham Canada; and MutS was a generous gift of
for GMS. Blood samples were collected in EDTA tubes, Scott Hamilton, USB)—were used to recognize seven of
and DNA was prepared from isolated white blood cells the eight possible single-base-pair mismatches and to
by standard organic solvent–extraction procedures. The nick the unmethylated strand of the mismatch-con-
GMS method was modiﬁed from that originally de- taining heteroduplex DNA at GATC sites. Approxi-
scribed by Nelson et al. (1993). A 100-mg sample of mately 60 mg heterohybrid DNA was incubated with
DNA from each individual was digested with PstI, was 120 mg MutS, 60 mg MutL, and 0.93 mg MutH in cleav-
phenol/chloroform extracted, and was dissolved in age buffer (2 mM ATP, 20 mM KCl, 50 mM Hepes
ddH2O. DNA from individual VII:5 was methylated by [KOH], pH 8.0, 5 mM MgCl2, 1 mM DTT, and 50 mg
use of E. coli Dam methylase (New England Biolabs). BSA/ml) for 60 min at 37C. The mixture was then
To conﬁrm methylation, aliquots of the DNA samples incubated with 200 U Exo III for 15 min at 37C to
from both individuals were digested separately with degrade all nicked, mismatch-containing DNA mole-
DpnI and MboI, which recognize and cleave methylated cules and yield single-stranded DNA (ssDNA) gaps. Fol-
and unmethylated GATC sites, respectively. The two lowing Exo III digestion, DNA was phenol/chloroform
DNA samples were denatured at 95C for 10 min and extracted and mixed with BNDC (benzolated naph-
then hybridized in 2 M sodium thiocyanate, 10 mM Tris thalated DEAE cellulose, previously equilibrated with
pH 8.0, 0.1 mM EDTA, and 8% formamide, with just 50 mM Tris-HCl, pH 8.0, 1 M NaCl). BNDC at high
enough water-saturated phenol added to form an emul- salt concentrations binds to the Exo III–generated
sion. This formamide phenol emulsion reassociation ssDNA gaps leaving mismatch-free DNA. The BNDC
technique (FPERT) facilitates the hybridization of allelic mixture was agitated for 4 h at room temperature and
restriction fragments£20 kb in size (Casna et al. 1986). then pelleted at 14,000 g for 10 min. The supernatant
The hybridization mixture was agitated for 17 h at room (containing the GMS-selected DNA) was chloroform ex-
tracted, reprecipitated, and dissolved in 500 ml TE buffer.temperature.
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Microsatellite-Marker Analysis comparison of the GMS versus linkage results obtained
for the markers tested on chromosomes 6 and 12.Microsatellite analysis was performed using oligonu-
cleotide primers obtained from Research Genetics. PCR
GMS Error Rateampliﬁcation involved direct incorporation of 35S-dATP
Markers D6S1281 and D6S1277 produced PCRinto the PCR product as described (Mirzayans et al.
products of approximately the correct locus size, but1995). A 1-ml portion of the 500-ml GMS pool was used
they did not yield signiﬁcant positive LOD scores infor each PCR reaction. Conventional linkage results
conventional linkage analyses (D6S1281, peak LODwere obtained from Mears et al. (1996). A total of 47
score 0.05 at 44 cM; D6S1277, peak LOD score 0.0 atmarkers on chromosomes 6 and 12 were tested by GMS,
50 cM [table 1]). Linkage analysis between these mark-but, since PCR products were not obtained in repeated
ers and IGDA actually resulted in signiﬁcant evidenceexperiments from either GMS or genomic samples for
in favor of exclusion of linkage when the Morton crite-D6S1019 and D12S392, these two loci were excluded
rion of LOD õ02 was used for exclusion of linkagefrom further analysis.
(D6S1281, LOD £-2 at 15 cM; D6S1277, LOD £-2 at
21 cM). The length of the IBD region detected by GMS
Results and ﬂanked by D6S344 and D6S477 is Ç6.9 cM. On
the basis of our simulation study (see Discussion) for a
Chromosome 6 Marker Results with GMS genome scan of two chromosomes with lengths 197 cM
The Research Genetics MapPairs screening set (ver- (chromosome 6) and 170.8 cM (chromosome 12), the
sion 6), with average spacing of 10 cM, was used to test probability that the two ﬁfth-degree cousins share an
for regions of IBD between the two individuals VII:5 and IBD region§6.9 cM is only .016 under the null hypothe-
VII:7 used in GMS. Markers on human chromosome 6 sis that no disease gene resides on either of the two
were tested ﬁrst, for, during the GMS procedure, we chromosomes (table 2). This ﬁnding is consistent with
had obtained evidence of linkage of IGDA to markers the GMS results indicating that the two affected ﬁfth-
on 6p (Mears et al. 1996). Examples of typical GMS degree cousins VII:5 and VII:7 share the same disease
results are shown in ﬁgure 2, and a summary of the gene in the region ﬂanked by D6S344 and D6S477. On
complete results is shown in ﬁgure 3. PCR products were the basis of the same simulation study, the probability
obtained for the markers D6S344, D6S1713, D6S1617, that two ﬁfth-degree cousins share two or more IBD
D6S477, D6S1006, D6S1281, and D6S1277 in dupli- segments in the two chromosomes of interest is only
cate PCR reactions. Haplotype analysis of these markers 0.5% (table 2). The probability that they share two or
in individuals VII:5 and VII:7 indicated that markers more IBD segments on chromosome 6 is conceivably
D6S344, D6S1713, D6S1617, D6S477, D6S1281, and smaller. This suggests that the positive results detected
D6S1006 were from a region of IBD (Mears et al. 1996). at D6S1281 and D6S1277 are false. However, either
Interestingly, for marker D6S477, a second allele of the one marker or both markers could lie in non–IGDA-
marker contained in the shared region of 6p was also associated regions of IBD.
obtained. Why this occurred is not clear, but it may Three markers (D6S1600, D6S277, and D6S263)
reﬂect a difﬁculty, in GMS, of removing all mismatch- that, on the basis of haplotype analysis, are within IBD
containing heterohybrids in situations in which only a regions were negative by GMS and therefore are false
small portion of heterohybrid molecules are mismatch negatives. Such loci could correspond to genomic re-
free. gions that, because of the particular restriction enzymes
used in the GMS protocol, were not recovered. Overall,
Chromosome 12 Marker Results with GMS therefore, a GMS error rate of Ç11% ([2/3]/45 mark-
The MapPairs (version 6) set of 18 markers spanning ers tested) was observed.
human chromosome 12 at Ç10-cM spacing was also
tested in the GMS sample. Chromosome 12 was selected Discussion
as a control chromosome for GMS, since it represents an
average-sized human chromosome. Appropriately sized IGDA is a rare autosomal dominant human ocular
abnormality in which the anterior segment of the eyePCR products were not obtained with any chromosome
12 marker, indicating that none of the chromosome 12 is maldeveloped. Starting at the 6-wk stage of human
development, the formation of the anterior chamber ofmarkers lay within regions of IBD (ﬁg. 4). Consistent
with this interpretation, conventional linkage analysis the eye is associated with three successive waves of neu-
ral crest cells that form Descemet’s membrane, cornealof markers on chromosome 12 excluded the entire chro-
mosome 12 from containing the IGDA locus, when the keratocytes and stroma, and the iris stroma, respectively
(Mann 1964). The anterior chamber of the eye is formedMorton criterion (LOD õ02 [Morton 1955]) was used
as evidence of exclusion of linkage. Table 1 displays a from the slitlike space between the ﬁrst and third waves
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Figure 2 Examples of results obtained from analysis of the GMS-selected DNA pool. The PCR was used to assay microsatellite markers
in DNA from VII:5, VII:7, the GMS-selected pool, and in a water control. The panels are the autoradiographs produced after electrophoresis
of PCR products. Samples used in PCR reactions are identiﬁed at the top of each ﬁgure. A, Example of positive GMS results obtained with
microsatellite marker D6S1006. A PCR product corresponding to one allele of D6S1006 is visible in the GMS lane and is shared with both
VII:5 and VII:7. B, Example of negative GMS results obtained with microsatellite marker D6S1056. No PCR product was obtained from the
GMS sample. C, Example of negative GMS results, together with the ampliﬁcation of an incorrectly sized PCR product in the GMS sample.
A PCR product was generated with primers for marker D6S1050 in the GMS sample but was of a size that did not correspond to the D6S1050
alleles generated with either VII:5 or VII:7.
of neural crest cells. The iridocorneal angle of the ante- tween IGDA and chromosome 6 markers in two families
(Mears et al. 1996). On the basis of haplotype analysisrior chamber deepens as the fetus matures, with the
angle’s ﬁnal positioning being completed only after the and identiﬁcation of recombinants, the IGDA locus is
mapped to a 8.3-cM interval, telomeric of D6S477, at1st year of life. IGDA, characterized by iris hypoplasia
and juvenile glaucoma, is the result of aberrant migra- 6p25.
A GMS-selected DNA pool from two ﬁfth-degree rela-tion or terminal induction of the neural crest cells in-
volved in anterior-chamber formation. This disorder tives with IGDA was generated in parallel with these
linkage experiments. Markers on the short arm of hu-was ﬁrst reported by Berg (1932), who described a large
pedigree in which iris hypoplasia was observed in all man chromosome 6 were recovered in the GMS-selected
DNA pool (ﬁg. 3), consistent with the linkage resultseyes with glaucoma. Berg postulated a maldevelopment
of the iridocorneal angle, a condition later proved by mapping the IGDA locus to 6p25. Markers on human
chromosome 12, excluded by linkage analysis from con-Jerndal (1972), who reexamined Berg’s original pedi-
gree, and by Weatherill and Hart (1969), who described taining the IGDA locus, were not recovered in the GMS-
selected DNA pool. The latter result indicates that thea British pedigree with IGDA. Gonioscopy of affected
individuals typically revealed, in the iridocorneal angle, positive recovery of loci in the GMS-selected DNA pool
was speciﬁc for regions of IBD.excess tissue that could increase resistance to aqueous
outﬂow, leading to glaucoma. The ﬁrst report describing GMS successfully demon-
strated that the GMS technique could be applied to iso-We have used two parallel lines of experimentation
to map the IGDA locus: conventional linkage analysis late IBD regions from yeast (Nelson et al. 1993). How-
ever, GMS has never been successfully applied toand the GMS-selected DNA-pool strategy to ﬁnd IBD
regions. After elimination of candidate regions for other humans—or, indeed, to multicelled organisms—until
this report. This inability might stem from an error inocular disorders, a genomewide scan for IGDA was per-
formed by use of linkage analysis. Approximately 95% the original protocol, in which 50 mM was inadvertently
indicated as the concentration of Hepes (KOH) in theof the genome was excluded with ú300 microsatellite
markers before signiﬁcant linkage was demonstrated be- MutHLS cleavage buffer, rather than the correct concen-
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tration, 50 mM, used here (S. Hamilton [USB], personal
communication). A second pitfall with GMS is that, al-
though it would appear to be a logical step to use the
GMS-selected products directly as in situ hybridization
probes on metaphase chromosomes, the minute amount
of DNA recovered after GMS selection could preclude
such an application. However, the simple and rapid test-
ing of microsatellite markers, as applied in this report,
is not affected by low-DNA yield.
Five of 45 markers successfully tested on chromo-
somes 6 and 12 yielded incorrect results with GMS, as
compared with linkage results with the IGDA family.
The three GMS false negatives (D6S1600, D6S277, and
D6S263, which all lie within a shared region, as deter-
mined by haplotype analysis; ﬁg. 3) could possibly reﬂect
loci eliminated from the GMS pool when the restriction
enzymes used in the GMS protocol happened to cleave
the DNAwithin or between the PCR primer pairs. Alter-
Figure 3 Schematic diagram of the GMS results for chromosome
6 markers from two ﬁfth-degree cousins with IGDA. Positions of
markers are indicated to the right, and distances (in cM) are indicated
to the left. GMS results are indicated to the immediate right of the
locus names. Blackened circles indicate the observation, in two inde-
pendent PCR assays, of a PCR product corresponding to a marker
allele present in both VII:5 and VII:7; an unblackened circle indicates
that no such PCR product was observed in two independent PCR
tests. A question mark (?) indicates a marker that completely failed
to generate PCR products in all samples, in repeated PCR tests. Link-
age results with chromosome 6 markers in the IGDA family have
indicated that IGDA maps to 6p25 (Mears et al. 1996). Family linkage
analysis reveals that individuals VII:5 and VII:7 share a haplotype
from D6S1600 to D6S1006 (indicated by a thick black bar to the far
right). Gray-shaded boxes indicate regions in which haplotypes could
not be unequivocally determined.
Figure 4 Schematic diagram of the GMS results for chromosome
12 from two ﬁfth-degree cousins with IGDA. Symbols are as in ﬁgure
3. There is no detectable region, on chromosome 12, of a shared
haplotype for individuals VII:5 and VII:7.
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Table 1
Comparison of GMS and Linkage Results for Chromosomes 6 and 12, with IGDA Family
Maximum Recombination Fraction
Marker GMSa Maximum LOD Score for Maximum LOD Score £ 02b
D6S942 0 9.32 at recombination fraction .00 NA
D6S1600 0 9.47 at recombination fraction .00 NA
D6S1617 / 10.63 at recombination fraction .00 NA
D6S477 / 7.73 at recombination fraction .03 NA
D6S277 0 7.98 at recombination fraction .03 NA
D6S1006 / 4.32 at recombination fraction .10 .00
D6S1050 0 1.26 at recombination fraction .22 .03
D6S1281 / .05 at recombination fraction .44 .15
D6S1031 0 .48 at recombination fraction .32 .07
D6S1056 0 .07 at recombination fraction .43 .16
D6S1040 0 .00 at recombination fraction .50 .21
D6S1003 0 .20 at recombination fraction .32 .05
D6S1277 / .00 at recombination fraction .50 .11
D6S1027 0 .00 at recombination fraction .50 .20
D12S372 0 .00 at recombination fraction .50 .12
D12S391 0 .17 at recombination fraction .41 .16
D12S1042 0 .00 at recombination fraction .50 .21
D12S398 0 .57 at recombination fraction .20 .01
D12S1294 0 .23 at recombination fraction .37 .09
D12S1052 0 .01 at recombination fraction .47 .16
D12S1064 0 .00 at recombination fraction .50 .13
PAH 0 .00 at recombination fraction .50 .22
D12S395 0 .00 at recombination fraction .50 .15
a A plus sign (/) indicates GMS-positive results in two independent PCR tests; and a minus sign (0)
indicates GMS-negative results in two independent PCR tests.
b Indicates exclusion of linkage (Morton 1955). NA Å not applicable.
natively, these false negatives could simply be due to were obtained with markers D6S1277 and D6S1281,
which were not signiﬁcantly linked to IGDA by familyGMS selection being a very stringent procedure. In either
case, a genome screening at 10-cM resolution, by GMS, linkage analysis. The PCR product obtained with these
two markers could indicate the locations of additionalwith selection for GMS of two individuals sharing an
appropriate degree of relation (see below), would usu- non–IGDA-associated regions of IBD between the two
individuals used in GMS or, alternatively, could repre-ally not miss the region of IBD. GMS positive results
Table 2
Simulation Results for Various Kinds of Cousin Relationships
Average Total Length
Relationship Average No. of IBD Segment Average Size of M
of Cousins P(N Å 0) P(N § 2) P(M § 6.9 cM)a of Segments (cM) (cM)
First degree .0062 .9537 .9765 4.1796 91.98 (91.95) 46.18
Second degree .2689 .4293 .5892 1.5161 22.78 (22.99) 16.01
Third degree .6478 .1110 .2267 .5060 5.76 (5.75) 4.80
Fourth degree .8785 .0250 .0661 .1510 1.48 (1.44) 1.32
Fifth degree .9622 .0052 .0164 .0436 .37 (.36) .34
Sixth degree .9870 .0012 .0051 .0142 .09 (.09) .09
NOTE.—The simulation was based on 10,000 replications. The numbers in parentheses are theoretical expectations, calculated on the basis
of computations explicated by Guo (1995).
a Probability that the length of the maximum IBD segment, M, in the two chromosomes is §6.9 cM (6.9 cM is the length of the IBD segment
detected by the GMS).
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sent spurious PCR products of approximately the cor- ample used here, for a pair of ﬁfth-degree cousins, n
Å 12. Given a pair of individuals with known relation-rect size, generated in the absence of the correct locus.
Consistent with the latter explanation, background PCR ship, and given the marker density d, it is possible to
calculate the probability that at least one marker isproducts not apparently PCR ampliﬁable from either of
the individuals used in GMS were obtained with several within the chromosomal region that surrounds the dis-
ease locus and that is shared IBD by the two relatives.markers (ﬁg. 2C). Presumably, primer-site competition
by the correct primary locus, when present, apparently If it is assumed that all markers within the IBD segment
can be identiﬁed by the GMS method, the aforemen-precludes ampliﬁcation from these secondary sites. Since
any GMS-generated positives would be immediately tioned probability equals the probability of not missing
the IBD region containing the disease gene when a ge-conﬁrmed by family linkage analysis, the GMS error
rate is well within an acceptable range for a rapid, ﬁrst nome scanning of resolution d is used. Under the as-
sumptions of no interference, no sex difference in mapscreening approach.
In this paper, we have advocated the use of GMS to length, inﬁnite chromosome length, and random distri-
bution of the disease locus, the probability, P, of missingexamine IBD regions shared by two distantly related
relatives, both affected with the same disease trait, as a the IBD region because of scanning at d (Morgan) reso-
lution is calculated as P Å 1 0 2/(d*n) / [(1/2/rapid means of mapping disease genes. This differs from
the method proposed by Feingold et al. (1993), in two (d*n)]exp(0d*n) (Boehnke 1994).
Table 3 presents the probability of ﬁnding at least oneaspects. First, whereas the method of Feingold et al.
(1993) assumes a complete high-resolution map (or, at marker in the shared IBD region containing the disease
gene, for various relationships and map densities. It canleast, equally spaced markers), our method does not
need such an assumption. Second, whereas their method be seen that, for a map density of 10 cM, the use of
relative pairs beyond sixth-degree cousins may jeopar-focuses primarily on multiple relative pairs of the same
kind, ours considers only a single pair of affected rela- dize the chance of ﬁnding any marker in the IBD region
containing the disease gene. We also performed a simu-tives. This applies to the situation in which the disease
of interest is rare and the line of descent is almost certain, lation study to investigate the properties of the IBD seg-
ments shared by the two affected relatives, under theas is the case that we describe in this paper. To minimize
the chance of getting false-positive results, it is important null hypothesis that no disease gene resides within the
chromosomes of interest. Simulation analyses were per-to select two affected individuals related distantly
enough that they would not share genes very often formed with two chromsomes, one 197 cM long and one
170.8 cM long. This choice resembles the chromsomes 6through IBD. However, one cannot select the pair too
distantly related, for two reasons. First, if the two indi- and 12 that we have scanned. We calculated various
statistics, including the probability that the two relativesviduals are too distantly related, the chance would be
high that the pair did not receive the mutant disease share no IBD segment at all (i.e., P[N Å 0], where N is
the number of IBD segments), the probability that theallele by IBD. If this happened, then GMS would be
useless. One can, of course, minimize this chance by two share at least two IBD segments in the two chromo-
somes being examined (i.e., P[N § 2]), the probabilitycarefully selecting the pair with known lines of descent.
Second, if the pair is too distantly related, then the length that the length of the maximum IBD segment M in the
two chromsomes is §6.9 cM (6.9 cM was chosen be-of the chromosomal segment containing the disease gene
and shared by the two relatives would be too small to cause the IBD segment detected by the GMS, ﬂanked by
D6S344 and D6S477, is 6.9 cM), average number ofbe detected, since any genetic map has a limited density.
In view of these two reasons, it is important to strike a IBD segments, average size of M, and average total
length of all IBD segments. The results are shown inbalance between the need for the rare opportunity of
sharing an IBD segment and the need for detecting the table 2. For the purpose of checking the results, the
average total length of IBD segments was also calculatedIBD chromosomal segment that surrounds the disease
locus. It should be pointed out, with regard to the pair and was compared with the theoretical calculations
based on the work of Guo (1995). It can be seen thatof interest, that the chance of sharing an IBD segment
depends not only on the relationship that the pair has the simulation results agree remarkably well with the
expected results (table 2). The table also shows, at leastbut also on the length of the genome that one scans. For
a pair of individuals with a particular relationship, the for the case that we have considered (i.e., two chromo-
somes, one 197 cM and the other 170.8 cM), that ﬁrst-,distribution of the length of the IBD segment sur-
rounding the disease locus is well known, given that the second-, and third-degree cousins have a moderate to
high probability of sharing at least two IBD segmentstwo share the same disease allele IBD (e.g., see Lange et
al. 1985; Boehnke 1994). Speciﬁcally, if the two individ- and tend to share longer IBD segments. In contrast, the
probability of sharing at least two IBD segments is negli-uals are n generations apart, then the distribution is g
with mean 2/n Morgans and variance 2/n2. For the ex- gible for fourth- or higher-degree cousins (table 2). In
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Table 3
Probability That at Least One Marker Residing in IBD Region Containing Disease Gene Is Shared by
Two Individuals with Various Relationships, for Different Marker Densities
PROBABILITY FOR DENSITY Å
(cM)
RELATIONSHIP
OF COUSINS 2 5 10 15 20
First degree .9990 .9940 .9781 .9551 .9273
Second degree .9977 .9871 .9551 .9122 .8635
Third degree .9961 .9781 .9273 .8635 .7957
Fourth degree .9940 .9673 .8964 .8127 .7293
Fifth degree .9915 .9551 .8635 .7621 .6670
Sixth degree .9886 .9417 .8297 .7133 .6100
Seventh degree .9854 .9273 .7957 .6670 .5588
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